Desmoprin Nasal Spray contains Desmopressin 0.1 mg/ml, a synthetic antidiuretic hormone analogue used for management of diabetes insipidus, nocturnal enuresis, and excessive urination disorders.
Desmopressin works by reducing urine production and improving water reabsorption, helping maintain normal fluid balance and preventing dehydration. Its nasal delivery ensures rapid absorption and effective therapeutic response.
Clinically, Desmoprin Nasal Spray is prescribed in endocrinology, pediatric, and urology practice, offering reliable symptom control and good patient compliance.
From a business perspective, Desmoprin Nasal Spray strengthens the hormonal and specialty therapy segment, delivering consistent prescription demand, repeat sales, and strong PCD pharma franchise potential at a best price for franchise partners.